本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

CLIMB BIO INC

2.48
+0.10004.20%
盤後2.490.0100+0.40%18:44 EDT
成交量:104.99萬
成交額:258.25萬
市值:1.68億
市盈率:-3.58
高:2.52
開:2.43
低:2.35
收:2.38
52周最高:8.79
52周最低:1.05
股本:6,776.41萬
流通股本:2,557.93萬
量比:1.09
換手率:4.10%
股息:- -
股息率:- -
每股收益(TTM):-0.6934
每股收益(LYR):-1.5343
淨資產收益率:-22.92%
總資產收益率:-15.83%
市淨率:0.90
市盈率(LYR):-1.62

資料載入中...

公司資料

公司名字:
CLIMB BIO INC
交易所:
NASDAQ
成立時間:
2018
員工人數:
18
公司地址:
20 William Street,Suite 145,Wellesley Hills,Massachusetts,United States
郵編:
02481
電話:
傳真:
- -
簡介:
Climb Bio, Inc.於2018年10月18日作為特拉華州公司註冊成立。該公司是一家生物技術公司,專註於開發神經元興奮性障礙的新療法,以解決精神病學、癲癇、慢性疼痛以及外周和中樞神經系統疾病方面未滿足的需求。

董事

名稱
職位
Andrew Levin
Chairman of the Board
Robert Azelby
Chief Executive Officer and Director
Adam Rosenberg
Director
Judith Dunn
Director
Leone Patterson
Director
Liam Ratcliffe
Director
Simon Tate
Director

股東

名稱
職位
Robert Azelby
Chief Executive Officer and Director
Erin M. Lavelle
Executive Vice President, Chief Operating Officer and Chief Financial Officer
James B. Bucher
Executive Vice President and General Counsel
Valerie Morisset
Executive Vice President, Research and Development and Chief Scientific Officer